A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies

Completed · Phase 4

Conditions studied: Myocardial Infarction, Coronary Artery Disease

In brief

The objective of this randomized trial is to evaluate the effect of providing full prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins, beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers to patients recently discharged from hospital after acute myocardial infarction.

Key facts

Study ID

NCT00566774

Run by

Brigham and Women's Hospital

People needed

5860

Starts

2007-11-01

Expected to finish

2010-11-01

Last updated by the study team

2016-01-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• discharged alive from hospital after acute MI
• receive health services and prescription drug benefits through Aetna, Inc.

You may not qualify if…

• enrollment in a Health Savings Account (HSA) plan
• age ≥ 65 years of age at the time of hospital discharge
• plan sponsor has opted out of participating in the study
• receive only medical services or pharmacy coverage but not both through Aetna

Where it is running

• Aetna Inc — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.